esophageal carcinoma

Showing 26 - 43 of 43

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Esophageal Carcinoma Trial in Amsterdam (Pertuzumab, trastuzumab)

Completed
  • Esophageal Carcinoma
  • Pertuzumab, trastuzumab
  • Amsterdam, Netherlands
    Academic Medical Center, Medical Oncology
Jun 29, 2020

Esophageal Carcinoma, Esophageal Cancer Trial in Utrecht (Esophagectomy)

Completed
  • Esophageal Carcinoma
  • Esophageal Cancer
  • Esophagectomy
  • Utrecht, Netherlands
    UMC Utrecht
Mar 25, 2020

Esophageal Cancer, Esophageal Carcinoma Trial in Nanjing, Nanchang, Shanghai (esophagectomy)

Recruiting
  • Esophageal Cancer
  • Esophageal Carcinoma
  • esophagectomy
  • Nanjing, Jiangsu, China
  • +5 more
Feb 3, 2020

Esophageal Carcinoma Trial in Beijing (concurrent chemoradiotherapy plus DC-CIK immunotherapy, Concurrent chemoradiation only)

Unknown status
  • Esophageal Carcinoma
  • concurrent chemoradiotherapy plus DC-CIK immunotherapy
  • Concurrent chemoradiation only
  • Beijing, Beijing, China
    Capital Medical University Cancer Center
Jan 2, 2020

Esophageal Carcinoma Trial in Beijing (SHR-1210, Docetaxel, Irinotecan)

Completed
  • Esophageal Carcinoma
  • SHR-1210
  • +2 more
  • Beijing, China
  • +1 more
Oct 23, 2019

Esophageal Carcinoma, Hypopharyngeal Carcinoma, Laryngeal Carcinoma Trial in Rochester, Omaha, Green Bay (Doxepin Hydrochloride,

Terminated
  • Esophageal Carcinoma
  • +13 more
  • Doxepin Hydrochloride
  • +3 more
  • Rochester, Minnesota
  • +2 more
Sep 10, 2019

Adenocarcinoma of the Gastroesophageal Junction, Esophageal Carcinoma Trial in Beijing (Icotinib)

Completed
  • Adenocarcinoma of the Gastroesophageal Junction
  • Esophageal Carcinoma
  • Beijing, Beijing, China
    Cancer Hospital, Chinese Academy of Medical Sciences
Jul 2, 2019

Endometrial Cancer, Fallopian Tube Cancer, Ovarian Cancer Trial in New York (Narrow Band Imaging (NBI))

Completed
  • Endometrial Cancer
  • +7 more
  • Narrow Band Imaging (NBI)
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Nov 6, 2018

Barrett Esophagus, Esophageal Carcinoma Trial in Tucson, Chapel Hill (Ursodiol, Laboratory Biomarker Analysis)

Completed
  • Barrett Esophagus
  • Esophageal Carcinoma
  • Tucson, Arizona
  • +3 more
Nov 22, 2017

Colon Cancer, Esophageal Carcinoma, Pancreatic Cancer Trial in Chendu (CAR-T cell immunotherapy)

Unknown status
  • Colon Cancer
  • +5 more
  • CAR-T cell immunotherapy
  • Chendu, China
    IEC of Chengdu Medical College
Jan 4, 2017

Esophageal Carcinoma Trial in Ann Arbor (Tetrathiomolybdate (TM), Radiation, Surgery)

Completed
  • Esophageal Carcinoma
  • Tetrathiomolybdate (TM)
  • +2 more
  • Ann Arbor, Michigan
    University of Michigan Cancer Center
Jul 12, 2016

Diffusion-weighted Magnetic Resonance Imagingfor Early Response

Unknown status
  • Esophageal Carcinoma
  • DW-MRI
  • Changsha, Hunan, China
    Hunan province tumor pospital
Aug 15, 2016

Esophageal Carcinoma Trial in Guangzhou (Liposomal Paclitaxel, Nedaplatin)

Completed
  • Esophageal Carcinoma
  • Guangzhou, Guangdong, China
    Medical Oncology,Sun Yat-sen University Cancer Center
Aug 5, 2016

Esophageal Carcinoma Trial in New York (Cisplatin, Irinotecan, External Beam Radiation Therapy)

Completed
  • Esophageal Carcinoma
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Dec 18, 2015

Esophageal Carcinoma Trial (Bevacizumab, cetuximab)

Withdrawn
  • Esophageal Carcinoma
  • Bevacizumab, cetuximab
  • (no location specified)
Nov 18, 2013

Esophageal Carcinoma Trial in Hangzhou (intensity modulated radiation therapy in both arms, concurrent chemo with radiation)

Unknown status
  • Esophageal Carcinoma
  • intensity modulated radiation therapy in both arms
  • concurrent chemotherapy with radiation
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Sep 3, 2013

Esophageal Carcinoma Trial in Taian (lobaplatin , 5-FU ,leucovorin)

Unknown status
  • Esophageal Carcinoma
  • lobaplatin , 5-FU ,leucovorin
  • Taian, Shandong, China
    Taian Cancer Hospital
Jan 4, 2010

Esophageal Carcinoma Trial in Beijing, Guangzhou, Shanghai (, Sodium Glycididazole)

Unknown status
  • Esophageal Carcinoma
  • placebo
  • Sodium Glycididazole
  • Beijing, Beijing, China
  • +3 more
May 13, 2008